5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial.

[1]  Anna Lena Lopez,et al.  Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study. , 2012, The Lancet. Infectious diseases.

[2]  J. Holmgren.  A case for control of cholera in Africa by vaccination. , 2012, The Lancet. Infectious diseases.

[3]  Anna Lena Lopez,et al.  The global burden of cholera. , 2012, Bulletin of the World Health Organization.

[4]  Allan Donner,et al.  Efficacy of a Low-Cost, Inactivated Whole-Cell Oral Cholera Vaccine: Results from 3 Years of Follow-Up of a Randomized, Controlled Trial , 2011, PLoS neglected tropical diseases.

[5]  J. Clemens,et al.  Vaccines in the time of cholera , 2011, Proceedings of the National Academy of Sciences.

[6]  F. Qadri,et al.  Oral vaccines for preventing cholera. , 2011, The Cochrane database of systematic reviews.

[7]  N. T. Hien,et al.  Use of Oral Cholera Vaccines in an Outbreak in Vietnam: A Case Control Study , 2011, PLoS neglected tropical diseases.

[8]  Allan Donner,et al.  Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial , 2009, The Lancet.

[9]  J. Kirigia,et al.  Economic burden of cholera in the WHO African region , 2009 .

[10]  S. Plotkin,et al.  Vaccines: correlates of vaccine-induced immunity. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  Jin-Kyung Park,et al.  Long-term effectiveness against cholera of oral killed whole-cell vaccine produced in Vietnam. , 2006, Vaccine.

[12]  J. Clemens,et al.  Effectiveness of mass oral cholera vaccination in Beira, Mozambique. , 2005, The New England journal of medicine.

[13]  D. Sack,et al.  Cholera in Mozambique, Variant of Vibrio cholerae , 2004, Emerging infectious diseases.

[14]  D. Sack,et al.  Field trial of inactivated oral cholera vaccines in Bangladesh: results from 5 years of follow-up. , 1996, Vaccine.

[15]  A. Svennerholm,et al.  Protective efficacy of oral whole-cell/recombinant-B-subunit cholera vaccine in Peruvian military recruits , 1994, The Lancet.

[16]  Z. Ying,et al.  Checking the Cox model with cumulative sums of martingale-based residuals , 1993 .

[17]  Lee-Jen Wei,et al.  Cox-Type Regression Analysis for Large Numbers of Small Groups of Correlated Failure Time Observations , 1992 .

[18]  Yunus,et al.  Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up , 1990, The Lancet.

[19]  L. J. Wei,et al.  The Robust Inference for the Cox Proportional Hazards Model , 1989 .

[20]  Nancy Reid,et al.  Influence functions for proportional hazards regression , 1985 .